Regulation of endothelial cell gap formation and paracellular permeability
- PMID: 7735915
Regulation of endothelial cell gap formation and paracellular permeability
Abstract
Investigation of the regulation of permeability properties of the endothelium has yielded evidence to support the concept of a dual regulation of EC gap formation and barrier function. In this model, the primary determinants of EC permeability are tethering/adhesive properties (Figure 1) and tensile centripetal force generation (Figure 2). The importance of actin-myosin interactions and active cellular contraction and force generation has been reviewed. In the model of thrombin-induced EC barrier dysfunction, there is a strong shift in the MLC species from the unphosphorylated to the diphosphorylated form, indicating activation of MLCK, a key enzyme whose importance in EC contraction has been well established. Although important differences between EC and SMC exist, endothelial cell gap formation involves actomyosin-dependent contractile mechanisms similar to SMC, a cellular system in which MLC phosphorylation correlates with the initial rate of tension development. The increase in MLC phosphorylation and isometric tension is consistent with the hypothesis that activation of signal transduction mediates an increase in isometric tension to a new level of "latch state" through the cytoskeleton. Thus, the available evidence implicates a strong role for cellular force generation and contraction in the evolution of thrombin-induced barrier dysfunction. Accumulating evidence also indicates that modulation of tethering properties, primarily those involving cell-matrix and cell-cell adhesion, is also a key determinant of basal EC barrier properties as well as agonist-mediated barrier dysfunction. Because each of these focal adhesion constituents may be involved in establishing tethering properties in endothelium, they each may be involved in determining barrier permeability and may be involved in the evolution of agonist-mediated barrier dysfunction. Therefore, in addition to MLCK-dependent active tensile force generation, agonist-induced barrier dysfunction may occur via MLCK-independent pathways that rely on basal levels of MLC phosphorylation or by affecting proteins involved in tethering properties of endothelium that contribute to barrier function. Further examination of tethering force properties, combined with elucidation of EC relaxation via MLC dephosphorylation may yield clues as to how this important vascular barrier is maintained and restored after vascular insult.
Similar articles
-
Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation.J Cell Physiol. 1995 Jun;163(3):510-22. doi: 10.1002/jcp.1041630311. J Cell Physiol. 1995. PMID: 7775594
-
Regulation of thrombin-mediated endothelial cell contraction and permeability.Semin Thromb Hemost. 1996;22(4):309-15. doi: 10.1055/s-2007-999025. Semin Thromb Hemost. 1996. PMID: 8944415 Review.
-
Mechanisms of cholera toxin prevention of thrombin- and PMA-induced endothelial cell barrier dysfunction.Microvasc Res. 1994 Sep;48(2):212-35. doi: 10.1006/mvre.1994.1050. Microvasc Res. 1994. PMID: 7854206
-
Thrombin-mediated focal adhesion plaque reorganization in endothelium: role of protein phosphorylation.Am J Respir Cell Mol Biol. 1997 Oct;17(4):443-55. doi: 10.1165/ajrcmb.17.4.2502. Am J Respir Cell Mol Biol. 1997. PMID: 9376119
-
Direct effects of endotoxin on the endothelium: barrier function and injury.Lab Invest. 1999 Oct;79(10):1181-99. Lab Invest. 1999. PMID: 10532583 Review.
Cited by
-
Microviscoelasticity of the apical cell surface of human umbilical vein endothelial cells (HUVEC) within confluent monolayers.Biophys J. 2004 Aug;87(2):1338-50. doi: 10.1529/biophysj.103.037044. Biophys J. 2004. PMID: 15298936 Free PMC article.
-
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier.Curr Neuropharmacol. 2008 Sep;6(3):179-92. doi: 10.2174/157015908785777210. Curr Neuropharmacol. 2008. PMID: 19506719 Free PMC article.
-
An intronic MYLK variant associated with inflammatory lung disease regulates promoter activity of the smooth muscle myosin light chain kinase isoform.J Mol Med (Berl). 2012 Mar;90(3):299-308. doi: 10.1007/s00109-011-0820-9. Epub 2011 Oct 21. J Mol Med (Berl). 2012. PMID: 22015949
-
Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells.J Biol Chem. 2009 Jul 10;284(28):19053-66. doi: 10.1074/jbc.M109.000521. Epub 2009 May 7. J Biol Chem. 2009. PMID: 19423710 Free PMC article.
-
Statins as a novel therapeutic strategy in acute lung injury.Pulm Circ. 2012 Oct;2(4):397-406. doi: 10.4103/2045-8932.105028. Pulm Circ. 2012. PMID: 23372924 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous